105 results on '"Amiot, A"'
Search Results
2. Su1503: REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
3. Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
4. Sa1769 PERSISTENCE OF BOWEL URGENCY DESPITE CLINICAL REMISSION AFTER INDUCTION THERAPY IS ASSOCIATED WITH UNFAVORABLE LONG-TERM OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE MULTICENTER UC-RGENCY STUDY.
5. 1178 PROMISING EFFICACY OF SMALL MOLECULES AND BIOLOGICALS FOR MICROSCOPIC COLITIS: RESULTS FROM A LARGE REAL-LIFE MULTICENTER COHORT
6. Frequency of Mitochondrial Defects in Patients With Chronic Intestinal Pseudo-Obstruction
7. Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
8. Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
9. Mo1565: EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY
10. 457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY
11. Sa554 CHRONIC POUCHITIS AND CROHN'S DISEASE OF THE POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS : INCIDENCE AND RISK FACTORS
12. Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY
13. Sa1772 DIETARY INDEX BASED ON THE FOOD STANDARD AGENCY NUTRIENT PROFILING SYSTEM AND RISK OF CROHN'S DISEASE AND ULCERATIVE COLITIS: A EUROPEAN PROSPECTIVE COHORT STUDY
14. 14 REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY
15. Sa1744 IMPACT OF LINE OF THERAPY, THERAPEUTIC ESCALATION OR DE-ESCALATION ON ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SUB-ANALYSIS FROM THE PROSPECTIVE NATIONWIDE STUDY ACCEPT2.
16. Sa1743 ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE NATIONWIDE STUDY (ACCEPT2).
17. Sa554 CHRONIC POUCHITIS AND CROHN'S DISEASE OF THE POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS : INCIDENCE AND RISK FACTORS
18. 457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY
19. Sa1743 ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PROSPECTIVE NATIONWIDE STUDY (ACCEPT2)
20. Sa1744 IMPACT OF LINE OF THERAPY, THERAPEUTIC ESCALATION OR DE-ESCALATION ON ACCEPTABILITY OF TREATMENT REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SUB-ANALYSIS FROM THE PROSPECTIVE NATIONWIDE STUDY ACCEPT2
21. Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease
22. Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease
23. Mo1873 - Efficacy of Infliximab after Failure of Subcutaneous Antitnf Agent in Patients with Ulcerative Colitis: A Multicenter Study
24. Mo1785 - Long-Term Outcome of Crohn's Disease Complicated by Upper Gastrointestinal Stricture: A Getaid Cohort Study
25. Mo1785 - Long-Term Outcome of Crohn's Disease Complicated by Upper Gastrointestinal Stricture: A Getaid Cohort Study
26. Mo1873 - Efficacy of Infliximab after Failure of Subcutaneous Antitnf Agent in Patients with Ulcerative Colitis: A Multicenter Study
27. Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid
28. Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid
29. Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
30. 1072 Rate and Predictors of Mucosal Healing in Patients With Ulcerative Colitis Treated With Thiopurines: Results of a Multicentric Cohort Study
31. 313 Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease
32. 1121 Autoimmune Pancreatitis Associated With Inflammatory Bowel Disease: A Multicentric Study of the GETAID
33. Sa1949 A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study
34. 1072 Rate and Predictors of Mucosal Healing in Patients With Ulcerative Colitis Treated With Thiopurines: Results of a Multicentric Cohort Study
35. 1121 Autoimmune Pancreatitis Associated With Inflammatory Bowel Disease: A Multicentric Study of the GETAID
36. 313 Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease
37. Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
38. Sa1949 A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study
39. 595 Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience
40. Mo1939 Performance of a Blood Methylated Mutitarget DNA Test (Colohybritest) for the Diagnosis of Colorectal (CRC) Cancer: A Transversal Study on 878 Individuals
41. Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus
42. 829 Long-Term Outcomes in a Cohort of Patients With Acute Severe Ulcerative Colitis Refractory to Intravenous Steroids Treated With Cyclosporine or Infliximab
43. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction
44. 829 Long-Term Outcomes in a Cohort of Patients With Acute Severe Ulcerative Colitis Refractory to Intravenous Steroids Treated With Cyclosporine or Infliximab
45. Mo1939 Performance of a Blood Methylated Mutitarget DNA Test (Colohybritest) for the Diagnosis of Colorectal (CRC) Cancer: A Transversal Study on 878 Individuals
46. 595 Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience
47. Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus
48. 553 Risk of Dysplasia and Cancer Complicating Colonic Strictures in Inflammatory Bowel Disease: A GETAID Study
49. Su1392 Benefit of Infliximab Re-Introduction After Successive Failure of Infliximab and Adalimumab in Crohn's Disease
50. 341 Risk of Incident Cancer in Patients With Inflammatory Bowel Disease Starting Anti-TNF Therapy While Having Prior Malignancy Within Past 5 Years
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.